Division of Gastroenterology, Rabin Medical Center, Petah-Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Dig Dis. 2023;41(2):233-238. doi: 10.1159/000524883. Epub 2022 May 9.
Minimal data are available regarding the performance of video capsule endoscopy (VCE) in patients who underwent bariatric surgery. We aimed to report indications, feasibility, and safety of VCE performed after bariatric surgery, specifically focusing on diagnosis rates of Crohn's disease (CD) in this population.
A retrospective analysis of all VCE procedures was performed between January 2015 and December 2019. All patients who underwent bariatric surgery prior to VCE were included. Indication for VCE, ingestion methods, completion rates, retention rates, and endoscopic findings were recorded.
A total of 1,255 patients underwent VCE examination during the study period, of which 31 (2.5%) underwent bariatric surgery prior to VCE. The most common bariatric surgery was laparoscopic sleeve gastrectomy (16 patients, 51.6%), and the most common indication for VCE was evaluation of iron deficiency anemia (14 patients, 45.1%). The majority of patients ingested the capsule independently, without endoscopic assistance (20, 64.5%). Although a patency capsule was not used in our cohort, no events of capsule retention were documented. Mean transit time was 4.32 h. Only 4 events of incomplete examination were recorded. Over a median follow-up of 27.5 months (IQR 13.0-34.2), 10 patients (31.2%) had a final diagnosis of CD with a median Lewis score of 225 (IQR 135-900).
VCE is a feasible and safe procedure after bariatric surgery. Oral ingestion does not carry risk of retention. It is an effective means of diagnosis of small-bowel CD in this population.
有关肥胖症手术后行胶囊内镜(VCE)的表现的数据很少。我们旨在报告肥胖症手术后行 VCE 的适应证、可行性和安全性,特别关注该人群中克罗恩病(CD)的诊断率。
对 2015 年 1 月至 2019 年 12 月期间所有 VCE 检查进行回顾性分析。所有在 VCE 前接受过肥胖症手术的患者均被纳入研究。记录 VCE 的适应证、摄入方法、完成率、保留率和内镜检查结果。
在研究期间,共有 1255 例患者接受了 VCE 检查,其中 31 例(2.5%)在 VCE 前接受了肥胖症手术。最常见的肥胖症手术是腹腔镜袖状胃切除术(16 例,51.6%),最常见的 VCE 适应证是评估缺铁性贫血(14 例,45.1%)。大多数患者自行摄入胶囊,无需内镜协助(20 例,64.5%)。尽管我们的研究队列未使用通畅胶囊,但未记录到胶囊保留事件。平均转运时间为 4.32 小时。仅记录到 4 例检查不完全的事件。在中位数为 27.5 个月(IQR 13.0-34.2)的随访中,10 例(31.2%)患者最终诊断为 CD,中位 Lewis 评分为 225(IQR 135-900)。
肥胖症手术后行 VCE 是一种可行且安全的方法。口服摄入不会导致胶囊保留的风险。对于该人群的小肠 CD 诊断,它是一种有效的方法。